TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year EBIT Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
EBIT Growth(%) | 32.26 | 127.18 | - |
What is the latest EBIT Growth ratio of TRIDENT LIFELINE ?
Year | EBIT Growth |
---|---|
Mar2024 | 32.26 |
Mar2023 | 127.18 |
Mar2022 | - |
How is EBIT Growth of TRIDENT LIFELINE Trending?
Years | EBIT Growth | % Change | |
---|---|---|---|
Mar2024 | 32.26 | -74.63 | |
Mar2023 | 127.18 | 0 | |
Mar2022 | 0 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹286.9 Cr | -7% | -7.3% | 24.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,213.0 Cr | 3.9% | -3.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,403.0 Cr | 1.8% | -4.5% | 53.9% | Stock Analytics | |
CIPLA | ₹117,415.0 Cr | -0.6% | -0.3% | -2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,791.0 Cr | 1.2% | -3% | 14.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,228.2 Cr | -3% | -9.5% | -11.7% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -7% |
-7.3% |
24.2% |
SENSEX | 0.4% |
-4.9% |
-0.1% |
You may also like the below Video Courses